Early recombinant factor VIIa therapy in acute intracerebral hemorrhage: Promising approach

Neurology India

Volumn 54, Issue 1, 2006, Pages 24-27

  Kumar, Sudhir ^a,a   Badrinath, H R ^a  

^a APOLLO HOSPITAL   (India)

Author keywords

Acute intracerebral hemorrhage; Recombinant factor VIIa

Indexed keywords

FIBRINOGEN; HEMOGLOBIN A1C; MANNITOL; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN;

ANGINA PECTORIS; ARTIFICIAL VENTILATION; ASIAN; BLOOD CLOTTING DISORDER; BLOOD PRESSURE REGULATION; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONSERVATIVE TREATMENT; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FIBRINOLYSIS; HEART INFARCTION; HUMAN; LUNG EMBOLISM; MORTALITY; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; STROKE; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 33646754921     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: 10.4103/0028-3886.24697     Document Type: Review

References (21)

1. Sacco RL, Mayer SA. Epidemiology of intracerebral hemorrhage. In: Feldmann E, editor. Intracerebral Hemorrhage. Armonk, NY: Futura Publishing Co; 1994. p. 3-23.
2. Counsell C, Boonyakarnkul S, Dennis M. Primary intracerebral hemorrhage in the Oxfordshire Community Stroke Project. 2. Prognosis. Cerebrovasc Dis 1995;5:26-34.
3. Broderick JP, Adams HP Jr, Barsan W, Feinberg W, Feldmann E, Grotta J, et al. Guidelines for the management of spontaneous intracerebral hemorrhage:a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999;30:905-15.
4. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage:a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993;24:987-93.
5. Hemphill JC III, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score:a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001;32:891-7.
6. G. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997;28:1-5.
7. Mayer SA. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke 2003;34:224-9.
8. Kazui S, Minematsu K, Yamamoto H, Sawada, T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997;28:2370-5.
9. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998;39:1160-6.
10. Murai Y, Takagi R, Ikeda Y, Yamamoto Y, Teramoto A. Three-dimensional computerized tomography angiography in patients with hyperacute intracerebral hemorrhage. J Neurosurg 1999;91:424-31.
11. Becker KJ, Baxter AB, Bybee HM, Tirschwell DL, Abouelsaad T, Cohen WA. Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke 1999;30:2025-32.
12. Hedner U. Recombinant factor Vlla (NoroSeven®) as a haemostatic agent. Bloodline Reviews 2001;1:3-4.
13. Hoffman M, Monroe DM, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets:thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinol 1998;9:S61-5.
14. Erhardtsen E. Ongoing NovoSeven® trials. Intensive Care Med 2002;28:S248-56.
15. Mayer SA, Brun N, Broderick J, Davis S, Diringer MN, Skolnick BE, et al. Europe/ AustralAsia NovoSeven ICH Trial Investigators. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 2005;36:74-9.
16. Lee KR, Colon GP, Betz AL, Keep RF, Kim S, Hoff JT. Edema from intracerebral hemorrhage:the role of thrombin. J Neurosurg 1996;84:91-6.
17. Mayer SA, Brun N, Davis S, Broderick J, Diringer MN, Steiner T. For the US NovoSeven ICH Trial Investigators. Safety and preliminary efficacy of recombinant coagulation factor VIIa in acute intracerebral hemorrhage: US Phase 2A Study. Stroke 2004;35:332.
18. Skolnick BE, Brun NC, Kruse P, Seremetis SV. Safety and laboratory results for recombinant activated coagulation factor VII in patients with acute intracerebral hemorrhage. Blood 2003;102:307a.
19. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. For the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005;352:777-85.
20. Roberts HR. Recombinant factor Vlla (NovoSeven®) and the safety of treatment. Semin Hematol 2001;38:48-50.
21. Broderick PJ. Advances in the treatment of hemorrhagic stroke: A possible new treatment. Cleveland Clin J Med 2005;72:342-4.